Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

Legalizing marijuana, an opinion from a former JAMA editor

George Lundberg, MD
Meds
May 23, 2010
Share
Tweet
Share

While I was still the editor of JAMA, I was in Boston in January, 1997, to do my regular teaching at Harvard. I dropped in to see my friend Jerry Kassirer, the editor of the New England Journal of Medicine. Little did I know that Jerry was in the midst of a firestorm of protest for his just-published editorial called “Federal Foolishness and Marijuana.” Jerry told me that he received more response to that editorial than anything else he had ever written.

Six months later, at Brown University, David Lewis and 36 other distinguished physicians founded Physician Leadership for National Drug Policy [now Physicians and Lawyers for National Drug Policy] (www.plndp.org). PLNDP was begun to persuade the United States to deal with psychoactive drugs by applying scientific best evidence rather than the myths, lies, religion, and ideology our country had been using.

In 2005, I published a Webcast Video Editorial on Medscape, demanding that the U.S. government reclassify marijuana from a Schedule I drug. The response to that editorial was mostly supportive. Opinion was changing.

Fast forward to 2010. In this publication, more than 80% of some 1,800 (and counting) physicians in a current MedPage Today survey responded that marijuana should be reclassified from Schedule I. Great progress!

As a forensic pathologist, I know that tobacco and alcohol kill every day in most American cities, legally. To my knowledge, marijuana has never toxicologically killed any one.

There was that one student at UCLA who choked on a bolus of weed while trying to destroy the evidence when the cops broke in. And there may have been one man in the Netherlands who smoked multiple consecutive pipe loads of high-grade hash, successfully killing himself. It is true that if one takes marijuana leaves, seeds, and stems, cooks a soup, and shoots the “pot porridge,” one gets really sick, as we reported from LA County years ago. And, it is obvious that flying an airplane or driving a car while stoned is a very bad idea.

I don’t use grass myself and I don’t recommend it; but for patients with terminal HIV or cancer, if they find palliative relief from medical marijuana, why not?

As to the broader question of recreational use, regulation, and taxation, I suspect that there will be a lot of unintended consequences when that first American state takes those legal steps, probably fairly soon.

George Lundberg is a MedPage Today Editor-at-Large and former editor of the Journal of the American Medical Association.

Originally published in MedPage Today. Visit MedPageToday.com for more health policy news.

Prev

Evidence based medicine at the expense of the art of medicine

May 23, 2010 Kevin 21
…
Next

Communication and coordination of care needs to be compensated

May 23, 2010 Kevin 6
…

Tagged as: Medications

Post navigation

< Previous Post
Evidence based medicine at the expense of the art of medicine
Next Post >
Communication and coordination of care needs to be compensated

ADVERTISEMENT

More by George Lundberg, MD

  • a desk with keyboard and ipad with the kevinmd logo

    Pathologists face a stark career choice

    George Lundberg, MD
  • a desk with keyboard and ipad with the kevinmd logo

    A culture of cover-up has slowed the patient safety movement

    George Lundberg, MD
  • a desk with keyboard and ipad with the kevinmd logo

    Do drugs aid and abet genius or does genius lead to drugs?

    George Lundberg, MD

More in Meds

  • Are you neurodivergent or just bored?

    Martha Rosenberg
  • Pharmacy benefit manager reform vs. direct drug plans

    Leah M. Howard, JD
  • A cautionary tale about pramipexole

    Anonymous
  • My persistent adverse reaction to an SSRI

    Scott McLean
  • Tofacitinib: a lesson in heart-immune health

    Larry Kaskel, MD
  • The case for regulating, not banning, kratom

    Heidi Sykora, DNP, RN
  • Most Popular

  • Past Week

    • How to fight for your loved one during a medical crisis [PODCAST]

      The Podcast by KevinMD | Podcast
    • A new autism care model in Idaho

      Ronald L. Lindsay, MD | Conditions
    • Protecting elder clinicians from violence

      Gerald Kuo | Conditions
    • China’s health care model of scale and speed

      Myriam Diabangouaya, MD & Vikram Madireddy, MD | Physician
    • The myth of endless availability in medicine

      Emmanuel Chilengwe | Conditions
    • Bureaucratic evil in modern health care

      Dr. Bryan Theunissen | Conditions
  • Past 6 Months

    • Why you should get your Lp(a) tested

      Monzur Morshed, MD and Kaysan Morshed | Conditions
    • Rebuilding the backbone of health care [PODCAST]

      The Podcast by KevinMD | Podcast
    • The dismantling of public health infrastructure

      Ronald L. Lindsay, MD | Physician
    • The flaw in the ACA’s physician ownership ban

      Luis Tumialán, MD | Policy
    • The decline of the doctor-patient relationship

      William Lynes, MD | Physician
    • Rethinking cholesterol and atherosclerosis

      Larry Kaskel, MD | Conditions
  • Recent Posts

    • How to fight for your loved one during a medical crisis [PODCAST]

      The Podcast by KevinMD | Podcast
    • Is trauma surgery a dying field?

      Farshad Farnejad, MD | Physician
    • Gen Z, ADHD, and divided attention in therapy

      Ronke Lawal | Conditions
    • Innovation in medicine: 6 strategies for docs

      Jalene Jacob, MD, MBA | Tech
    • Why we fund unproven autism therapies

      Ronald L. Lindsay, MD | Physician
    • Early-onset breast cancer: a survivor’s story

      Sara Rands | Conditions

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

View 39 Comments >

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

ADVERTISEMENT

  • Most Popular

  • Past Week

    • How to fight for your loved one during a medical crisis [PODCAST]

      The Podcast by KevinMD | Podcast
    • A new autism care model in Idaho

      Ronald L. Lindsay, MD | Conditions
    • Protecting elder clinicians from violence

      Gerald Kuo | Conditions
    • China’s health care model of scale and speed

      Myriam Diabangouaya, MD & Vikram Madireddy, MD | Physician
    • The myth of endless availability in medicine

      Emmanuel Chilengwe | Conditions
    • Bureaucratic evil in modern health care

      Dr. Bryan Theunissen | Conditions
  • Past 6 Months

    • Why you should get your Lp(a) tested

      Monzur Morshed, MD and Kaysan Morshed | Conditions
    • Rebuilding the backbone of health care [PODCAST]

      The Podcast by KevinMD | Podcast
    • The dismantling of public health infrastructure

      Ronald L. Lindsay, MD | Physician
    • The flaw in the ACA’s physician ownership ban

      Luis Tumialán, MD | Policy
    • The decline of the doctor-patient relationship

      William Lynes, MD | Physician
    • Rethinking cholesterol and atherosclerosis

      Larry Kaskel, MD | Conditions
  • Recent Posts

    • How to fight for your loved one during a medical crisis [PODCAST]

      The Podcast by KevinMD | Podcast
    • Is trauma surgery a dying field?

      Farshad Farnejad, MD | Physician
    • Gen Z, ADHD, and divided attention in therapy

      Ronke Lawal | Conditions
    • Innovation in medicine: 6 strategies for docs

      Jalene Jacob, MD, MBA | Tech
    • Why we fund unproven autism therapies

      Ronald L. Lindsay, MD | Physician
    • Early-onset breast cancer: a survivor’s story

      Sara Rands | Conditions

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

Legalizing marijuana, an opinion from a former JAMA editor
39 comments

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...